Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Accurate accumulation of dose for improved understanding of radiation effects in normal tissue.

Jaffray DA, Lindsay PE, Brock KK, Deasy JO, Tomé WA.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S135-9. doi: 10.1016/j.ijrobp.2009.06.093. Review.

2.

Developments in radiotherapy.

Svensson H, Möller TR; SBU Survey Group..

Acta Oncol. 2003;42(5-6):430-42.

PMID:
14596505
3.

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

Suit H, Kooy H, Trofimov A, Farr J, Munzenrider J, DeLaney T, Loeffler J, Clasie B, Safai S, Paganetti H.

Radiother Oncol. 2008 Feb;86(2):148-53. doi: 10.1016/j.radonc.2007.12.024. Epub 2008 Jan 30.

PMID:
18237800
4.

Significance and implementation of RBE variations in proton beam therapy.

Paganetti H.

Technol Cancer Res Treat. 2003 Oct;2(5):413-26.

PMID:
14529306
5.

Clinical controversies: proton therapy for pediatric tumors.

Merchant TE.

Semin Radiat Oncol. 2013 Apr;23(2):97-108. doi: 10.1016/j.semradonc.2012.11.008. Review.

6.

Recent advances in light ion radiation therapy.

Brahme A.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):603-16. Review.

PMID:
14751534
7.

Radiotherapy techniques in current use in Sweden.

Möller TR, Ceberg J, Einhorn N, Lindholm C, Nylén U, Svensson H; SBU Survey Group..

Acta Oncol. 2003;42(5-6):376-86.

PMID:
14596501
9.

Dose- and LET-painting with particle therapy.

Bassler N, Jäkel O, Søndergaard CS, Petersen JB.

Acta Oncol. 2010 Oct;49(7):1170-6. doi: 10.3109/0284186X.2010.510640. Erratum in: Acta Oncol. 2013 Feb;52(2):458.

PMID:
20831510
10.

Current concepts in clinical radiation oncology.

Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihöfer C, Schüttrumpf L, Ernst A, Niemöller OM, Belka C.

Radiat Environ Biophys. 2014 Mar;53(1):1-29. doi: 10.1007/s00411-013-0497-2. Epub 2013 Oct 20. Review.

11.

Normal tissue toxicity after small field hypofractionated stereotactic body radiation.

Milano MT, Constine LS, Okunieff P.

Radiat Oncol. 2008 Oct 31;3:36. doi: 10.1186/1748-717X-3-36. Review.

12.

Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.

Martin S, Johnson C, Brophy M, Palma DA, Barron JL, Beauchemin SS, Louie AV, Yu E, Yaremko B, Ahmad B, Rodrigues GB, Gaede S.

Acta Oncol. 2015 Mar;54(3):322-32. doi: 10.3109/0284186X.2014.970666. Epub 2014 Oct 28.

PMID:
25350526
13.

The management of imaging dose during image-guided radiotherapy: report of the AAPM Task Group 75.

Murphy MJ, Balter J, Balter S, BenComo JA Jr, Das IJ, Jiang SB, Ma CM, Olivera GH, Rodebaugh RF, Ruchala KJ, Shirato H, Yin FF.

Med Phys. 2007 Oct;34(10):4041-63.

14.

Quantifying variability in radiation dose due to respiratory-induced tumor motion.

Geneser SE, Hinkle JD, Kirby RM, Wang B, Salter B, Joshi S.

Med Image Anal. 2011 Aug;15(4):640-9. doi: 10.1016/j.media.2010.07.003. Epub 2010 Jul 14.

PMID:
20674466
15.

[Coming technical advances in radiation oncology].

Suit H.

Z Med Phys. 2005;15(4):215-27. Review. German.

PMID:
16422350
16.

Treatment planning for molecular targeted radionuclide therapy.

Siantar CH, Vetter K, DeNardo GL, DeNardo SJ.

Cancer Biother Radiopharm. 2002 Jun;17(3):267-80. Review.

PMID:
12136519
17.

Three-dimensional radiation treatment planning study for patients with carcinoma of the lung.

Graham MV, Matthews JW, Harms WB Sr, Emami B, Glazer HS, Purdy JA.

Int J Radiat Oncol Biol Phys. 1994 Jul 30;29(5):1105-17.

PMID:
8083080
18.

"SABER": A new software tool for radiotherapy treatment plan evaluation.

Zhao B, Joiner MC, Orton CG, Burmeister J.

Med Phys. 2010 Nov;37(11):5586-92.

PMID:
21158270
20.

Proton therapy: clinical gains through current and future treatment programs.

Mohan R, Bortfeld T.

Front Radiat Ther Oncol. 2011;43:440-64. doi: 10.1159/000322509. Epub 2011 May 20. Review.

PMID:
21625168

Supplemental Content

Support Center